Buy Istamet

Istamet

Istamet: What Is It?

Istamet is a combination pill that contains sitagliptin and metformin. It belongs to the diabetes management category and is formulated as a tablet (pill) with a fixed strength of 50 mg sitagliptin / 1000 mg metformin per tablet. In Hong Kong, Istamet is a prescription-only medication that is regulated by the Hong Kong SAR Department of Health.

How Istamet Works in the Body

• Sitagliptin: This component is a dipeptidyl-peptidase-4 (DPP-4) inhibitor. By blocking the DPP-4 enzyme, sitagliptin prolongs the activity of incretin hormones (GLP-1 and GIP), which increase insulin secretion and decrease glucagon release when blood glucose is elevated.
• Metformin: Metformin primarily reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. It also modestly decreases intestinal absorption of glucose.

Together, these actions help lower blood glucose levels with complementary mechanisms-one enhancing insulin response, the other reducing glucose output.

Conditions Treated with Istamet

Istamet is approved for the treatment of type 2 diabetes mellitus in adults. It is indicated when diet, exercise, and monotherapy with either sitagliptin or metformin alone do not provide adequate glycemic control. The combination is intended for patients who require both an incretin-based therapy and a biguanide to achieve target blood-glucose levels.

Off-Label and Investigational Applications

Currently, there are no well-established off-label uses for the sitagliptin/metformin combination that meet rigorous peer-reviewed evidence standards. Any consideration of off-label use should be made under direct medical supervision, with a clear understanding that such use is not approved by regulatory agencies and requires individualized risk assessment.

Who Should (Not) Use Istamet?

Absolute Contraindications

• Known hypersensitivity to sitagliptin, metformin, or any tablet excipients.
• Severe renal impairment (eGFR < 30 mL/min/1.73 m²) because metformin accumulation can increase the risk of lactic acidosis.
• Acute or chronic metabolic acidosis, including diabetic ketoacidosis.

Relative Contraindications

• Moderate renal impairment (eGFR 30-45 mL/min/1.73 m²): dose adjustments or alternative therapy may be needed.
• Hepatic disease: metformin is contraindicated in severe hepatic impairment.
• Pregnancy and lactation: sitagliptin is not recommended; metformin is generally continued only when benefits outweigh potential risks.

Special Populations

• Elderly: May have reduced renal function; monitor kidney function regularly.
• Patients with heart failure: Use caution due to metformin-associated risk of lactic acidosis.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Gastrointestinal upset (nausea, diarrhea, abdominal discomfort) - commonly reported with metformin.
• Upper respiratory tract infection symptoms.
• Headache.

Serious Adverse Events

• Lactic acidosis (rare but potentially fatal) - signs include unexplained weakness, rapid breathing, abdominal pain, or severe nausea.
• Severe hypersensitivity reactions such as skin rash or angioedema.
• Pancreatitis (very rare) associated with DPP-4 inhibitors.

Drug Interactions

• Major: Concomitant use of potent CYP 2C8 inhibitors (e.g., gemfibrozil) may increase sitagliptin exposure.
• Moderate: Co-administration with iodinated contrast agents may transiently impair renal function, heightening metformin-related lactic acidosis risk.
• General advice: Patients should disclose all prescription medicines, over-the-counter drugs, supplements, and herbal products to their healthcare provider before starting Istamet.

Food and Lifestyle Interactions

• Metformin absorption is not significantly affected by meals, but taking the tablet with food can reduce gastrointestinal discomfort.
• Alcohol intake may increase the risk of lactic acidosis; limit consumption and discuss with a provider.
• No known effect on driving or use of machinery.

How to Take Istamet

• Standard dosing: One tablet (50 mg sitagliptin / 1000 mg metformin) taken orally once daily, preferably with the largest meal of the day to reduce gastrointestinal upset.
• Dose adjustments: In patients with moderate renal impairment, the prescribing clinician may reduce the metformin component or increase the dosing interval.
• Administration: Swallow the tablet whole with a glass of water; do not crush or chew.
• Missed dose: Take the missed tablet as soon as remembered on the same day; do not double the next dose.
• Overdose: Symptoms may include severe nausea, vomiting, abdominal pain, and respiratory distress. Seek emergency medical care; treatment focuses on supportive measures and, if necessary, dialysis for metformin removal.
• Discontinuation: Istamet can be stopped abruptly under medical guidance. No mandatory taper is required, but blood-glucose levels should be monitored closely.

Monitoring and Follow-Up

• Renal function: Check serum creatinine or eGFR before starting therapy and at least annually thereafter, or more frequently in at-risk patients.
• Glycemic control: Monitor HbA1c every 3-6 months to assess efficacy.
• Lactic acidosis signs: Educate patients to report unexplained fatigue, rapid breathing, or abdominal pain promptly.

Storage and Handling

• Store tablets at room temperature (15 °C-30 °C), protected from moisture and light.
• Keep the medication out of reach of children.
• Do not use tablets beyond the expiration date printed on the package.

Medication-Specific Glossary

DPP-4 Inhibitor

A class of drugs that block the dipeptidyl-peptidase-4 enzyme, prolonging the action of incretin hormones to enhance insulin secretion.

Biguanide

A drug class that includes metformin; it lowers blood glucose by decreasing hepatic glucose production and improving insulin sensitivity.

Lactic Acidosis

A rare but serious metabolic complication characterized by an accumulation of lactate in the body, potentially precipitated by metformin accumulation in patients with impaired renal function.

Medical Disclaimer

This article provides educational information about Istamet and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.